Its not just the debt, it has other current liabilities it needs...

Its not just the debt, it has other current liabilities it needs to offset/pay with cash, plus ongoings. Given very little revenue (maybe Oct reopen of DSV and trickle of revenue?), you can see why management flag more capital will likely be required at a later time.

DNA said it had 26.7m pro forma cash at June 30. However debt owed is 28.3m including the Aristo loan. Both loans are pretty much due in full within the next year and are current. So net debt of about 1.6m, plus other current liabilities DNA is pushing out with respect to suppliers, and the 800k monthly cash burn target ongoing. Its obvious more money will be needed to sure up the current asset deficit. The coming dillution will further reduce upside. Size of raising will depend on how much cash they can make in the back half of HY21.